Topiramate vs Levetiracetam
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.
Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.
Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.
See our Terms of Use and Editorial Policy.
Topiramate (Topamax) and levetiracetam (Keppra) are both widely prescribed anticonvulsant medications used to treat epilepsy and prevent seizures. While both are effective, they differ significantly in their side effect profiles and additional uses beyond epilepsy.
Topiramate works through multiple mechanisms including blocking sodium channels, enhancing GABA activity, and inhibiting carbonic anhydrase. Levetiracetam binds to the synaptic vesicle protein SV2A, modulating neurotransmitter release. These different mechanisms mean they have distinct clinical profiles.
Topiramate vs Levetiracetam: Side-by-side comparison
| Category | Topiramate | Levetiracetam |
|---|---|---|
| Drug Class | Anticonvulsant (multi-mechanism) | Anticonvulsant (SV2A ligand) |
| Brand Name | Topamax | Keppra |
| Common Dose Range | 100-400 mg/day | 1000-3000 mg/day |
| Titration Speed | Slow (weeks) | Fast (1-2 weeks) |
| Migraine Prevention | FDA-approved | Not approved |
| Weight Effect | Weight loss common | Weight neutral |
| Key Side Effect | Cognitive dulling | Irritability/mood changes |
| Drug Interactions | Moderate | Minimal |
Efficacy: How well does each drug work?
Both topiramate and levetiracetam are effective as monotherapy or add-on therapy for focal seizures in adults and children. Clinical trials show comparable seizure reduction rates of approximately 50% or greater in many patients.
Levetiracetam has a broader range of approved seizure types including focal onset, myoclonic, and primary generalized tonic-clonic seizures. Topiramate also has FDA approval for migraine prevention, making it a dual-purpose option for patients with both conditions.
Levetiracetam is generally considered first-line due to its favorable drug interaction profile, while topiramate may be preferred when weight management or migraine prevention is also a goal.
Side effects comparison
Topiramate is associated with cognitive side effects including difficulty with word-finding, memory problems, and decreased concentration. It can also cause tingling in the hands and feet, kidney stones, and metabolic acidosis.
Levetiracetam's most notable side effect is behavioral and mood changes, including irritability, agitation, anxiety, and sometimes depression. These psychiatric effects can be significant in some patients.
Topiramate frequently causes appetite suppression and weight loss, which can be beneficial for some patients but problematic for others. Levetiracetam is generally weight-neutral. Both drugs can cause drowsiness and fatigue.
Cost comparison
Both topiramate and levetiracetam are available as affordable generics. Generic topiramate typically costs $10-$30 per month, and generic levetiracetam costs $15-$40 per month.
Most insurance plans cover both drugs on preferred tiers. Extended-release formulations cost more but may be covered with prior authorization.
Convenience and dosing
Levetiracetam is generally easier to start as it can be titrated to a therapeutic dose within 1-2 weeks. Topiramate requires slower titration over several weeks to minimize cognitive side effects.
Both drugs are taken twice daily in immediate-release forms, or once daily in extended-release versions. Levetiracetam has fewer drug interactions, making it simpler for patients on multiple medications.
Which is right for you?
If you experience migraines in addition to seizures, topiramate may address both conditions with a single medication. If you are overweight, topiramate's appetite-suppressing effects might be beneficial.
If you need sharp cognitive function, or have kidney stone history, levetiracetam may be better due to topiramate's cognitive side effects and kidney stone risk. If you have mood disorders, topiramate might be preferred since levetiracetam has higher behavioral side effect risk.
Both drugs are effective anticonvulsants with long safety track records. Your neurologist will consider your seizure type, other conditions, and lifestyle when recommending the best option.
Frequently asked questions
Do Topiramate and Levetiracetam interact?
MinorReferences
- [Observational] Topamax (topiramate) FDA Prescribing Information https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020844s041lbl.pdf Accessed 2026-03-01.
- [Observational] Keppra (levetiracetam) FDA Prescribing Information https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021035s099lbl.pdf Accessed 2026-03-01.
- [Observational] Epilepsy and Seizures Information https://www.ninds.nih.gov/health-information/disorders/epilepsy-and-seizures Accessed 2026-03-01.
Written and fact-checked by PrescriptionDrugs.org Editorial Team
Last updated: